Santiago Ferro
Chief Tech/Sci/R&D Officer chez CORE ONE LABS INC.
Fortune : 66 756 $ au 31/03/2024
Profil
Santiago Ferro currently works at Akome Biotech Ltd., as Chief Executive Officer and Core One Labs, Inc., as Chief Medical Officer & Director.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CORE ONE LABS, INC.
0,90% | 29/01/2024 | 417 225 ( 0,90% ) | 66 756 $ | 31/03/2024 |
Postes actifs de Santiago Ferro
| Sociétés | Poste | Début |
|---|---|---|
| CORE ONE LABS INC. | Chief Tech/Sci/R&D Officer | 05/05/2021 |
Akome Biotech Ltd.
 Akome Biotech Ltd. Pharmaceuticals: MajorHealth Technology Part of Core One Labs, Inc., Akome Biotech Ltd. is a Canadian company that manufactures psychedelic-based pharmaceutical products. The private company was founded by Fadia Saad. The CEO is Santiago Ferro. Akome Biotech was acquired by Core One Labs, Inc. on May 04, 2021 for $2.27 million. | Chief Executive Officer | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CORE ONE LABS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Akome Biotech Ltd.
Akome Biotech Ltd. Pharmaceuticals: MajorHealth Technology Part of Core One Labs, Inc., Akome Biotech Ltd. is a Canadian company that manufactures psychedelic-based pharmaceutical products. The private company was founded by Fadia Saad. The CEO is Santiago Ferro. Akome Biotech was acquired by Core One Labs, Inc. on May 04, 2021 for $2.27 million. | Health Technology |
